Giles M, Ulbricht C, Khalsa KP, Kirkwood CD, Park C, Basch E · J Herb Pharmacother (2005)
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
20 peer-reviewed studies
What the evidence says
Most Butterbur studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2002–2025 with a typical study size of 186 participants.
Based on 20 studies · 1 meta-analysis · 13 RCTs · 570 total participants
Confidence
Moderate confidenceBy outcome
4 studies in the last 5 years · Latest meta-analysis: 2024
Giles M, Ulbricht C, Khalsa KP, Kirkwood CD, Park C, Basch E · J Herb Pharmacother (2005)
Agosti R, Duke RK, Chrubasik JE, Chrubasik S · Phytomedicine (2006)
Lee DK, Gray RD, Robb FM, Fujihara S, Lipworth BJ · Clin Exp Allergy (2004)
Schapowal A · Phytother Res (2005)
Lee DK, Carstairs IJ, Haggart K, Jackson CM, Currie GP, Lipworth BJ · Clin Exp Allergy (2003)
Oelkers-Ax R, Leins A, Parzer P, Hillecke T, Bolay HV, Fischer J · Eur J Pain (2008)
Gex-Collet C, Imhof L, Brattström A, Pichler WJ, Helbling A · J Investig Allergol Clin Immunol (2006)
Jackson CM, Lee DK, Lipworth BJ · Ann Allergy Asthma Immunol (2004)
Diener HC, Rahlfs VW, Danesch U · Eur Neurol (2004)
Lee DK, Haggart K, Robb FM, Lipworth BJ · Clin Exp Allergy (2004)
Melzer J, Schrader E, Brattström A, Schellenberg R, Saller R · Phytother Res (2009)
Gray RD, Haggart K, Lee DK, Cull S, Lipworth BJ · Ann Allergy Asthma Immunol (2004)
In plain English: A 3-arm RCT (n=245) found Petasites extract 75mg twice daily reduced migraine attack frequency by 48% vs 26% for placebo (p=0.0012); the 50mg dose was not significantly better than placebo.
Lipton RB et al. · Neurology (2004)
In plain English: Future studies may explore traditional ancient medicines for migraine at basic science and clinical level, while currently adopted and new nutraceutical treatments may benefit from partnership with industry to engage in larger trials in humans.
Rajapakse T, Gantenbein AR. · Handbook of clinical neurology (2024)
In plain English: Given its favourable safety profile and lack of sedative side effects, Ze 339 offers a valuable alternative to antihistamines and should therefore continue to be considered by medical practitioners for the treatment of allergic rhinitis symptoms.
Merk VM, Boonen G, Butterweck V, Schapowal A. · Advances in respiratory medicine (2025)
In plain English: A randomized BMJ trial found butterbur as effective as cetirizine for seasonal allergic rhinitis, without the sedation.
Schapowal A et al. · BMJ (Clinical research ed.) (2002)
In plain English: A systematic review and meta-analysis of medicinal plants for allergic rhinitis included butterbur among effective options.
Lim XY et al. · PloS one (2024)
In plain English: A systematic review of herbal migraine treatments found butterbur among those with supportive randomized evidence.
Lopresti AL et al. · Phytotherapy research : PTR (2020)
In plain English: A randomized, double-blind trial found butterbur extract Ze339 had dose-dependent efficacy for intermittent allergic rhinitis.
Schapowal A et al. · Archives of otolaryngology--head & neck surgery (2004)
In plain English: Conclusion In summary, this systematic review highlights two herbal preparations, one from European/Western PT and one from AM, that appear to be promising options in the treatment of SAR.
Braunwalder C, Ertl J, Wullschleger M, Timm E, Wolf U. · International archives of allergy and immunology (2025)